Identification and characterisation of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene

Molecular Immunology

Volumn 34, Issue 8-9, 1997, Pages 577-582

  Huang, Qi Rong ^a   Morris, D ^a   Manolios, N ^a,b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Apo 1 Fas (CD95) gene; Apoptosis; Immune regulation; Promoter; Restriction fragment length polymorphism; Single strand conformation polymorphism; Systemic lupus erythematosus

Indexed keywords

ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; APOPTOSIS; GENE EXPRESSION; GENETICS; GENOTYPE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ENDODEOXYRIBONUCLEASE BSTNI; FAS ANTIGEN; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; GENE EXPRESSION; GENOTYPE; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS);

EID: 0031151509     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00081-3     Document Type: Article

References (15)

1. Amasaki Y., Kobayashi S., Takeda T., Ogura N., Jodo S., Nakabayashi T., Tsutsumi A., Fujisaku A. and Koike T. (1995) Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clinical and Experimental Immunology 99, 245-250.
2. Baumler C. B., Bohler T., Herr I., Benner A., Krammer P. H. and Debatin K. M. (1996) Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 88, 1741-1746.
3. Behrmann I., Walczak H. and Krammer P. H. (1994) Structure of the human APO-1 gene. European Journal of Immunology 24, 3057-3062.
4. Briggs M. R., Kadonaga J. T., Bell S. P., Tjian R. (1986) Purification and biochemical characterization of the promoter-specific transcription factor, Spl. Science 2344772,47-52.
5. Cheng J., Liu C., Koopman W. J. and Mountz J. D. (1995) Characterization of human Fas gene. Exon/intron organisation and promoter region. Journal of Immunologv 154, 1239-1245.
6. Emlen W., Niebur J. and Kadera R. (1994) Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. Journal of Immunology 152, 3685-3692.
7. Fisher G. H., Rosenberg F. J., Straus S. E., Dale J. K., Middleton L. A., Lin A. Y., Strober W., Lenardo M. J. and Puck J. M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
8. Leithauser F., Dhein J., Mechtersheimer G., Koretz K., Bruderlein S., Henne C., Schmidt A., Debatin K. M., Krammer P. H. and Moller P. (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Laboratory Investigation 69, 415-429.
9. Mysler E., Bini P., Drappa J., Ramos P., Friedman S. M., Krammer P. H. and Elkon K. B. (1994) The apoptosis-1/Fas protein in human systemic lupus erythematosus. Journal of Clinical Investigation 93, 1029-1034.
10. Rieux Laucat F., Le Deist F., Hivroz C., Roberts I. A., Debatin K. M., Fischer A., de Villartay J. P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
11. Rudert F., Visser E., Forbes L., Lindridge E., Wang Y. and Watson J. (1995) Identification of a silencer, enhancer, and basal promoter region in the human CD95 (Fas/APO-1) gene. DNA Cell Biology 14, 931-937.
12. Sheffield V. C., Beck J. S., Kwitek A. E., Sandstrom D. W. and Stone E. M. (1993) The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 16, 325-332.
13. Shuai K. (1994) Interferon-activated signal transduction to the nucleus. Current Opinions in Cell Biology 6, 253-259.
14. Sun X. M., Neuwirth C., Wade D. P., Knight B. L., Soutar A. K. (1995) A mutation (T-45C) in the promoter region of the low-density-lipoprotein (LDL)-receptor gene is associated with a mild clinical phenotype in a patient with heterozygous familial hypercholesterolaemia (FH). Human Molecular Genetics 4, 2125-2129.
15. Xerri L., Carbuccia N., Parc P., Hassoun J. and Birg F. (1995) Frequent expression of FAS/APO-I in Hodgkin's disease and anaplastic large cell lymphomas. Histopathology 27, 235-241.